Literature DB >> 22814571

Mobile phone-based antiretroviral adherence support in Vietnam: feasibility, patient's preference, and willingness-to-pay.

Bach Xuan Tran1, Stan Houston.   

Abstract

Feasibility of using mobile phone for antiretroviral treatment adherence support was assessed in a multi-site survey. Of 1,016 respondents, 84.5 % used mobile phones; 78.6 % found it effective for adherence aid, 44.8 % had privacy concerns, and 63.5 % expressed willingness-to-use the service. Willingness-to-pay was US$ 2.5/month. Text messaging (41.8 %) and direct calls by health workers (35.4 %) were preferred. Expressed preference for specific support service included direct counseling with physician (43.1 %), automated reminder for pills taking (29.1 %), regular information messages (21.3 %), and booking of clinic visits (16.5 %). These findings inform the design of adherence interventions using mobile phone in the Vietnamese setting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814571     DOI: 10.1007/s10461-012-0271-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  23 in total

Review 1.  Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances.

Authors:  Jeffrey I Campbell; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

2.  Engaging Patients through Mobile Phones: Demonstrator Services, Success Factors, and Future Opportunities in Low and Middle-income Countries.

Authors:  A Hartzler; T Wetter
Journal:  Yearb Med Inform       Date:  2014-08-15

3.  Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.

Authors:  M R Jordan; Y Obeng-Aduasare; H Sheehan; S Y Hong; N Terrin; D V Duong; N V Trung; C Wanke; N V Kinh; A M Tang
Journal:  Int J STD AIDS       Date:  2013-12-18       Impact factor: 1.359

Review 4.  Meta-analysis on the effect of text message reminders for HIV-related compliance.

Authors:  Jonathan E Mayer; Paul Fontelo
Journal:  AIDS Care       Date:  2016-08-01

Review 5.  Content guidance for mobile phones short message service (SMS)-based antiretroviral therapy adherence and appointment reminders: a review of the literature.

Authors:  Andrew Kerrigan; Nadi N Kaonga; Alice M Tang; Michael R Jordan; Steven Y Hong
Journal:  AIDS Care       Date:  2018-11-29

6.  A role for health communication in the continuum of HIV care, treatment, and prevention.

Authors:  Cecilia Tomori; Kathryn Risher; Rupali J Limaye; Lynn M Van Lith; Susannah Gibbs; Marina Smelyanskaya; David D Celentano
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

Review 7.  Clients' perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive, maternal, newborn, child, and adolescent health: a qualitative evidence synthesis.

Authors:  Heather Mr Ames; Claire Glenton; Simon Lewin; Tigest Tamrat; Eliud Akama; Natalie Leon
Journal:  Cochrane Database Syst Rev       Date:  2019-10-14

8.  High Treatment Retention Rate in HIV-Infected Patients Receiving Antiretroviral Therapy at Two Large HIV Clinics in Hanoi, Vietnam.

Authors:  Shoko Matsumoto; Junko Tanuma; Daisuke Mizushima; Ngoc Chi Thi Nguyen; Thanh Thuy Thi Pham; Cuong Duy Do; Tuan Quang Nguyen; Dung Thi Nguyen; Hoai Dung Thi Nguyen; Lam Tien Nguyen; Kinh Van Nguyen; Shinichi Oka
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

9.  Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study.

Authors:  Bach Xuan Tran; Long Thanh Nguyen; Nga Hoang Nguyen; Quynh Van Hoang; Jongnam Hwang
Journal:  Glob Health Action       Date:  2013-03-15       Impact factor: 2.640

10.  Willingness to receive text message medication reminders among patients on antiretroviral treatment in North West Ethiopia: A cross-sectional study.

Authors:  Mihiretu Kebede; Atinkut Zeleke; Mulusew Asemahagn; Fleur Fritz
Journal:  BMC Med Inform Decis Mak       Date:  2015-08-13       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.